BioCentury
ARTICLE | Product Development

Metabolic Milestones

March 26, 2007 7:00 AM UTC

The increasing prevalence of metabolic diseases has become a growing concern as studies continue to draw links between them and a wide array of comorbidities. As new targets and pathways come to light, the race is on to develop therapies with novel mechanisms that can be used in combination with existing drugs to improve treatment outcomes.

While the complex nature of metabolic disorders makes the discovery of a single silver bullet unlikely, the multi-layered signaling pathways involved have offered industry a wide range of new targets to pursue. ...